Cargando…

Conditional cause-specific survival after chemotherapy and local treatment for primary stage IV breast cancer: A population-based study

BACKGROUND: Conditional survival (CS) represents the probability of surviving for additional years after the patient has survived for several years, dynamically describing the survival rate of the patient with the varying time of survival. The aim of this study was to evaluate the conditional cause-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Min, Zhang, Pin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396969/ https://www.ncbi.nlm.nih.gov/pubmed/36016620 http://dx.doi.org/10.3389/fonc.2022.800813

Ejemplares similares

Aggressive Local Treatment Improves Survival in Stage IV Breast Cancer With Synchronous Metastasis
por: Lian, Chen-Lu, et al.
Publicado: (2020)

Primary Tumor Surgery for Patients with De Novo Stage IV Breast Cancer can Decrease Local Symptoms and Improve Quality of Life
por: Si, Yiran, et al.
Publicado: (2020)

Impact of breast surgery on survival of patients with stage IV breast cancer: a SEER population-based propensity score matching analysis
por: Lin, Yuxiang, et al.
Publicado: (2020)

Resection of the Primary Tumor Improves the Survival of Patients With Stage IV Gastric Neuroendocrine Carcinoma
por: Li, Zefeng, et al.
Publicado: (2022)

Chemotherapy Combined With Recombinant Human Endostatin (Endostar) Significantly Improves the Progression-Free Survival of Stage IV Soft Tissue Sarcomas
por: Liao, Zhichao, et al.
Publicado: (2022)

Impact of Postoperative Radiotherapy on Survival of Patients With de novo Stage IV Breast Cancer: A Population-Based Study From the SEER Database
por: Zhang, Jie, et al.
Publicado: (2021)

Impact of surgical management of primary tumors in stage IV breast cancer patients: a retrospective observational study based on SEER database
por: Xie, Ning, et al.
Publicado: (2022)

Efficacy of Metabolically Supported Chemotherapy Combined with Ketogenic Diet, Hyperthermia, and Hyperbaric Oxygen Therapy for Stage IV Triple-Negative Breast Cancer
por: İyikesici, Mehmet Salih, et al.
Publicado: (2017)

Survival of Black and White Patients With Stage IV Small Cell Lung Cancer
por: Shi, Huashan, et al.
Publicado: (2021)

Efficacy of Chemotherapy in Survival of Stage I Nasopharyngeal Carcinoma
por: Ma, Jia-Lin, et al.
Publicado: (2021)

Nomogram Predicts Overall Survival in Patients With Stage IV Thyroid Cancer (TC): A Population-Based Analysis From the SEER Database
por: Yang, Tianqing, et al.
Publicado: (2022)

Development and validation of nomogram models to predict radiotherapy or chemotherapy benefit in stage III/IV gastric adenocarcinoma with surgery
por: Ren, Xiangqing, et al.
Publicado: (2023)

Improvements in survival for patients with stage IV adenocarcinoma in the lung, diagnosed between 2010 – 2020 - A population-based registry study from Norway
por: Børø, Siri, et al.
Publicado: (2022)

Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology
por: Merloni, Filippo, et al.
Publicado: (2023)

Comparison of Survival Between Irreversible Electroporation Followed by Chemotherapy and Chemotherapy Alone for Locally Advanced Pancreatic Cancer
por: He, Chaobin, et al.
Publicado: (2020)

Surgery and chemotherapy cannot improve the survival of patients with early-stage mucosa-associated lymphoid tissue derived primary pulmonary lymphoma
por: Lin, Huahang, et al.
Publicado: (2022)

Causes of Death and Conditional Survival of Renal Cell Carcinoma
por: Shao, Ning, et al.
Publicado: (2019)

Stratification of Candidates for Induction Chemotherapy in Stage III-IV Nasopharyngeal Carcinoma: A Large Cohort Study Based on a Comprehensive Prognostic Model
por: Sun, Xue-Song, et al.
Publicado: (2020)

Impact of Surgical Margins in Breast Cancer After Preoperative Systemic Chemotherapy on Local Recurrence and Survival
por: Wimmer, K., et al.
Publicado: (2019)

The Effects of Different Induction Chemotherapy Cycles and Adjuvant Chemotherapy on the Survival Outcomes of Patients With Locally Advanced Nasopharyngeal Carcinoma
por: Liao, Shu, et al.
Publicado: (2022)

Stage IV EGFR Mutation-Negative and ALK Mutation-Negative Lung Adenocarcinoma: Long-Term Survival is Possible
por: Kedia, Shiksha, et al.
Publicado: (2015)

Local surgery improves survival in elderly patients with stage IV breast cancer: a population-based retrospective cohort study
por: Shen, Yongshi, et al.
Publicado: (2022)

Conversion Surgery for Stage IV Gastric Cancer
por: Zhang, Fei, et al.
Publicado: (2019)

The survival benefits of local surgery in stage IV breast cancer are not affected by breast cancer subtypes: a population-based analysis
por: Wu, San-Gang, et al.
Publicado: (2017)

The Effectiveness of Gastrectomy With Chemoradiotherapy Among Stage IV Gastric Adenocarcinoma: A Population-Based Analysis
por: Li, Shuchun, et al.
Publicado: (2020)

The Prognostic Impact of Lymph Node Dissection on Primary Tumor Resection for Stage IV Non–Small Cell Lung Cancer: A Population-Based Study
por: Zhang, Yudong, et al.
Publicado: (2022)

Could local surgery improve survival in de novo stage IV breast cancer?
por: Xiong, Zhenchong, et al.
Publicado: (2018)

Nomogram Predicts the Role of Primary Tumor Surgery on De Novo Stage-IV Breast Cancer Patients: A SEER-Based Competing Risk Analysis Model
por: Cui, Hanxiao, et al.
Publicado: (2022)

Residual tumor and primary debulking surgery vs interval debulking surgery in stage IV epithelial ovarian cancer
por: Sørensen, Sarah Mejer, et al.
Publicado: (2022)

Surgery Plus Chemotherapy Versus Surgery Alone for Limited-Stage Small-Cell Lung Cancer: A Population-Based Survival Outcome Analysis
por: Ye, Pingting, et al.
Publicado: (2021)

Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia
por: Engel, Nils W., et al.
Publicado: (2019)

Stage IV non-small cell lung cancer among young individuals: Incidence, presentations, and survival outcomes of conventional therapies
por: Cai, Jing-Sheng, et al.
Publicado: (2022)

The Survival Outcomes of T1aN0M0 Triple-Negative Breast Cancer With Adjuvant Chemotherapy
por: Fu, Wen-Fen, et al.
Publicado: (2020)

Chemotherapy Decision-Making and Survival Outcomes in Older Women With Early Triple-Negative Breast Cancer: Evidence From Real-World Practice
por: Xiu, Meng, et al.
Publicado: (2022)

Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: Perioperative and Survival Outcomes
por: Ma, Xiao, et al.
Publicado: (2022)

Development and validation of a new stage-specific nomogram model for predicting cancer-specific survival in patients in different stages of colon cancer: A SEER population-based study and external validation
por: Hu, Chenhao, et al.
Publicado: (2022)

Overall survival and cancer-specific survival were improved in local treatment of metastatic prostate cancer
por: Miao, Qi, et al.
Publicado: (2023)

Editorial: Recent advancements in neoadjuvant chemotherapy for specific breast cancer subtypes
por: Adham, Sirin A., et al.
Publicado: (2022)

A Novel Staging System to Forecast the Cancer-Specific Survival of Patients With Resected Gallbladder Cancer
por: Yan, Yongcong, et al.
Publicado: (2020)

Timing of Chemotherapy and Radiotherapy Following Breast-Conserving Surgery for Early-Stage Breast Cancer: A Retrospective Analysis
por: Chen, Si-Ye, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3ehmdeie1sj7t47intogagkthi